Separation of bone-marrow-toxic factors from high molecular urine fractions of healthy persons and patients with uremia through dialysis in a desaggregated system
Brunner, H.; Essers, U.; Lamberts, B.; Heintz, R.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1459-1462
1976
ISSN/ISBN: 0070-4067 PMID: 1030020 Document Number: 106091
Document emailed within 1 workday
Related Documents
Lamberts, B.; Brunner, H.; Ochs, H.G.; Heintz, R. 1976: Effect of high-molecular urine fractions of healthy persons and patients with uremia on the rate of gluconeogenesis in kidney cortex slices of the rat Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1453-1456Smoleński, O. 1989: Effect of hemodialysate and its peptide fractions on stromal cells and heme synthesis in bone marrow culture and the activity of selected enzymes and GSH level of human erythrocytes. I. Effect on LDH activity in healthy persons and patients with terminal renal failure Przeglad Lekarski 46(10): 723-727
Protsenko, V.A.; Shpak, S.I.; Kritenko, G.I. 1981: Cationic protein content of bone marrow myeloid cells in healthy persons and in acute and chronic myeloleukemia patients Problemy Gematologii i Perelivaniia Krovi 26(8): 54-56
Ianovskiĭ, O.G.; Zakharova, L.A.; Vasilenko, A.M. 1990: Effects of high and low molecular soluble factors of the bone marrow on antibody formation and pain sensitivity in animals Biulleten' Eksperimental'noi Biologii i Meditsiny 109(1): 55-57
Fürst, P.; Bergström, J.; Gordon, A.; Johnsson, E.; Zimmerman, L. 1975: Separation of peptides of "middle" molecular weight from biological fluids of patients with uremia Kidney International. Supplement 1975(3): 272-275
Gruzdev, G.P.; Suvorova, L.A.; Vialova, N.A.; Pokrovskaia, V.N. 1980: Aspects of the quantitative bone marrow analysis of healthy persons Problemy Gematologii i Perelivaniia Krovi 25(9): 41-45
Rogova, E.M.; Domracheva, E.V.; Brilliant, M.D. 1981: Bone marrow fibroblast colony formation (CFU phi) efficiency in hematologically healthy persons Problemy Gematologii i Perelivaniia Krovi 26(7): 39-40
Merino, A.; Urbano-Ispizua, A.; Marín, P.; Besson, I.; Carreras, E.; Sierra, J.; Salgado, C.; Rovira, M.; Grañena, A.; Montserrat, E. 1993: Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation Sangre 38(5): 359-364
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
De Kreuk, M.; Ossenkoppele, G.J.; Meijer, C.J.; Huijgens, P.C. 1996: Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 17(6): 963-971
Israilov, A.I. 1982: X-ray cardiometric indices of healthy persons and patients with diffuse toxic goiter in the alpine climate of the Tien Shan Kardiologiia 22(4): 31-34
Blinov, M.N.; Vladimirova, A.D.; Luganova, I.S. 1978: Low-molecular weight nuclear RNA in the lymphocytes of healthy persons and chronic lympholeukemia patients Voprosy Onkologii 24(5): 14-17
Bearman, S.I.; Petersen, F.B.; Schor, R.A.; Denney, J.D.; Fisher, L.D.; Appelbaum, F.R.; Buckner, C.D. 1990: Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity Bone Marrow Transplantation 5(3): 173-177
Navone, R.; Pich, A.; Angeli, G. 1988: Histologic changes of the bone marrow in patients with chronic renal insufficiency undergoing dialysis Pathologica 80(1066): 137-143
Navone, R.; Viberti, L.; Vigliani, R. 1986: Evaluation of bone marrow hemosiderin in a case-load of bone marrow biopsies with special reference to situations with high iron deposits Pathologica 78(1053): 25-33
Yoshida, Y.; Osmond, D.G. 1978: Homing of bone marrow lymphoid cells. Localization and fate of newly formed cells in lymphocyte-rich marrow fractions injected into lethally X-irradiated recipients Transplantation 25(5): 246-251
Vasdev, S.; Johnson, E.; Longerich, L.; Prabhakaran, V.M.; Gault, M.H. 1987: Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients Clinical Nephrology 27(4): 169-174
Giannone, L.; Wolff, S.N. 1987: Phase Ii treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation Cancer Treatment Reports 71(7-8): 759-761
Or, R.; Nagler, A.; Shpilberg, O.; Elad, S.; Naparstek, E.; Kapelushnik, J.; Cass, Y.; Gillis, S.; Chetrit, A.; Slavin, S.; Eldor, A. 1996: Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients Transplantation 61(7): 1067-1071
Burtis, C.A.; Butts, W.C.; Rainey, W.T. 1970: Separation of the metabolites of phenacetin in urine by high-resolution anion exchange chromatography American Journal of Clinical Pathology 53(5): 769-777